DIA 2022 Global Annual Meeting

Component Type: Workshop

The industry is looking toward new site network models focused on community-based clinics. By being embedded in the community, new site networks have the opportunity to increase patient recruitment and convenience, improve retention, and enhance diversity in clinical trials. We will discuss strategies and ways non-traditional site networks could transform the clinical trial delivery model.

The COVID-19 pandemic illustrated how non-traditional community-based retail pharmacies / clinics could quickly recruit and see patients for vaccine clinical trials. It raises the questions of if these community-based pharmacies / clinics can enhance:

Recruitment: With large retail client bases, extensive pharmacy and EHR records, and customer analytics and insights, can new site networks recruit patients faster?

Retention: With convenient locations and expanded hours, telemedicine and digital / decentralized trial capabilities, and patient engagement initiatives, can they improve patient retention throughout the study?

Diversity: Can they build on the trust of pharmacists to improve the rate of patients participating in clinical trials and can they recruit more diverse populations -- more representative of the communities where they are at scale across multiple states versus what we see at traditional academic medical centers?

Learning Objectives

Recognize how retail pharmacies and other community-based clinics are transforming the clinical trial site delivery model; Describe how these retailers and community-based clinics can increase recruitment, enhance patient retention, and improve clinical trial diversity; Discover opportunities to build a new ecosystem of clinical trial site networks.

Chair

Dawn Anderson, BSN

Speaker

Panelist
Marc R. Watkins